Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
46%
OVERLAP
BY WEIGHT
40
# OF OVERLAPPING
HOLDINGS
XBI
122
HOLDINGS
34%
ALSO IN BBP
BBP
65
HOLDINGS
66%
ALSO IN XBI
SECTOR DRIFT (XBI minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
| CRISPR THERAPEUTICS AG | 2.2% | 2.0% | 2.0% | |
| IONIS PHARMACEUTICALS, INC. | 1.9% | 2.7% | 1.9% | |
| INSMED INC | 1.8% | 3.3% | 1.8% | |
| ROIVANT SCIENCES LTD. | 1.8% | 1.8% | 1.8% | |
| INCYTE CORP | 1.8% | 2.0% | 1.8% | |
XBI Overweight Relative to BBP
| REVOLUTION MEDICINES, INC. | 2.0% | |
| EXACT SCIENCES CORP | 2.0% | |
| NATERA INC | 1.9% | |
| ABBVIE INC | 1.8% | |
| AVIDITY BIOSCIENCES INC | 1.8% | |
| AKERO THERAPEUTICS, INC. | 1.5% | |
| VIKING THERAPEUTICS, INC. | 1.4% | |
| SUMMIT THERAPEUTICS INC | 1.4% | |
| VAXCYTE, INC. | 1.3% | |
| CYTOKINETICS INC | 1.2% |
XBI Underweight Relative to BBP
| BEIGENE LTD. SPONSORED ADR | -2.9% | |
| INTRA-CELLULAR THERAPIES INC | -2.6% | |
| ASCENDIS PHARMA A/S | -2.6% | |
| PHATHOM PHARMACEUTICALS, INC. | -2.5% | |
| SAGE THERAPEUTICS INC | -2.5% | |
| MIRUM PHARMACEUTICALS, INC. | -2.5% | |
| LIGAND PHARMACEUTICALS-CL B | -2.4% | |
| THERAVANCE BIOPHARMA INC | -2.3% | |
| BLUEPRINT MEDICINES CORP. | -2.3% | |
| LEXICON PHARMACEUTICALS, INC. | -2.2% |